Pulmonary myeloid cell uptake of biodegradable nanoparticles conjugated with an anti-fibrotic agent provides a novel strategy for treating chronic allergic airways disease

Amlan Chakraborty, Anita A. Pinar, Maggie Lam, Jane E. Bourke, Simon G. Royce, Cordelia Selomulya, Chrishan S. Samuel

Research output: Contribution to journalArticlepeer-review

122 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Pulmonary myeloid cell uptake of biodegradable nanoparticles conjugated with an anti-fibrotic agent provides a novel strategy for treating chronic allergic airways disease'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science